http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005026117-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2005026117-A1
titleOfInvention Stroke recurrence inhibitor
abstract The present invention relates to provision of a novel stroke recurrence inhibitor and a simple method for evaluating a stroke recurrence inhibitor. According to a simple evaluation method using stroke-prone spontaneous hypertension (SHR-SP) rats established by the present inventors, atorvastatin is effective in suppressing the recurrence of stroke, the effect of reducing neurological symptoms due to recurrent stroke, and the onset of stroke It was confirmed to have an effect of improving the survival rate later. Therefore, atorvastatin is useful as a stroke recurrence inhibitor.
priorityDate 2003-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID244551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453748563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412135435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23706212
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9809749
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448850249
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID287024
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422176981
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID342977
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450470952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54080534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452349496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452541451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536469
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457502397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19913901

Total number of triples: 55.